Arkolith/Insider Trading/FNCH/Form 4

Haft Nicholas

DirectorFinch Therapeutics Group, Inc. (FNCH) · full profile →Form 4 · filed Dec 22, 2021
Net Buying
Open-Market Buys
$650K
Open-Market Sells
$0
Net Open-Market Flow
$650K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2021Buy(P)64K$10.18$650K4.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-21-022453) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML